These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Device Therapy for Heart Failure with Preserved Ejection Fraction. Salah HM; Levin AP; Fudim M Cardiol Clin; 2022 Nov; 40(4):507-515. PubMed ID: 36210134 [TBL] [Abstract][Full Text] [Related]
13. Interatrial Shunting for Heart Failure: Early and Late Results From the First-in-Human Experience With the V-Wave System. Rodés-Cabau J; Bernier M; Amat-Santos IJ; Ben Gal T; Nombela-Franco L; García Del Blanco B; Kerner A; Bergeron S; Del Trigo M; Pibarot P; Shkurovich S; Eigler N; Abraham WT JACC Cardiovasc Interv; 2018 Nov; 11(22):2300-2310. PubMed ID: 30391390 [TBL] [Abstract][Full Text] [Related]
14. Left Atrial Decompression Using Unidirectional Left-to-Right Interatrial Shunt: Initial Experience in Treating Symptomatic Heart Failure With Preserved Ejection Fraction With the W-Wave Device. Amat-Santos IJ; Del Trigo M; Bergeron S; Pibarot P; Altisent O; Campelo-Parada F; Puri R; Verheye S; Keren G; Katzenellenbogen R; Rozenfeld E; Abraham WT; Bernier M; Rodés-Cabau J JACC Cardiovasc Interv; 2015 May; 8(6):870-872. PubMed ID: 25999114 [No Abstract] [Full Text] [Related]
15. Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure With Preserved Ejection Fraction (REDUCE LAP-HF I [Reduce Elevated Left Atrial Pressure in Patients With Heart Failure]): A Phase 2, Randomized, Sham-Controlled Trial. Feldman T; Mauri L; Kahwash R; Litwin S; Ricciardi MJ; van der Harst P; Penicka M; Fail PS; Kaye DM; Petrie MC; Basuray A; Hummel SL; Forde-McLean R; Nielsen CD; Lilly S; Massaro JM; Burkhoff D; Shah SJ; Circulation; 2018 Jan; 137(4):364-375. PubMed ID: 29142012 [TBL] [Abstract][Full Text] [Related]
16. Creation of a restrictive atrial left-to-right shunt: a novel treatment for heart failure. De Rosa R; Schranz D Heart Fail Rev; 2018 Nov; 23(6):841-847. PubMed ID: 30267205 [TBL] [Abstract][Full Text] [Related]
17. Influence of Left Atrial Function on Exercise Capacity and Left Ventricular Function in Patients With Heart Failure and Preserved Ejection Fraction. von Roeder M; Rommel KP; Kowallick JT; Blazek S; Besler C; Fengler K; Lotz J; Hasenfuß G; Lücke C; Gutberlet M; Schuler G; Schuster A; Lurz P Circ Cardiovasc Imaging; 2017 Apr; 10(4):. PubMed ID: 28360259 [TBL] [Abstract][Full Text] [Related]
18. The sHunt for better breathing in heart failure with preserved ejection fraction. Borlaug BA Eur J Heart Fail; 2014 Jul; 16(7):709-11. PubMed ID: 24920438 [No Abstract] [Full Text] [Related]
19. The AFR-PRELIEVE trial: a prospective, non-randomised, pilot study to assess the Atrial Flow Regulator (AFR) in heart failure patients with either preserved or reduced ejection fraction. Paitazoglou C; Özdemir R; Pfister R; Bergmann MW; Bartunek J; Kilic T; Lauten A; Schmeisser A; Zoghi M; Anker S; Sievert H; Mahfoud F EuroIntervention; 2019 Aug; 15(5):403-410. PubMed ID: 31130524 [TBL] [Abstract][Full Text] [Related]
20. Treatment With an Interatrial Shunt in Heart Failure: 1-Year Outcomes of the PRELIEVE Study. Paitazoglou C; Bergmann MW; Kilicaslan B; Kilic T; Bartunek J; Pfister R; Iliadis C; Kaya EB; Ozdemir R JACC Heart Fail; 2024 Mar; 12(3):591-594. PubMed ID: 38180430 [No Abstract] [Full Text] [Related] [Next] [New Search]